AstraZeneca PLC has doubled capacity to 2bn doses of coronavirus (COVID-19) vaccine after fresh funding from Bill Gates’ organisation.
Late on Thursday, the FTSE 100-listed firm signed a US$750mln deal with global vaccine organisations CEPI (part of the Bill & Melinda Gates Foundation) and Gavi to deliver 300mln doses at the end of the year.
It also reached a licensing agreement with the Serum Institute of India to supply 1bn doses for low-and-middle-income countries.
www.proactiveinvestors.co.uk/companies/amp/news/921259?__twitter_impression=true
Tess
Views: